REVIEW   Free

Italian Journal of Vascular and Endovascular Surgery 2021 June;28(2):59-62

DOI: 10.23736/S1824-4777.21.01467-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Risks of emergency vascular surgery in COVID-19 patients

Raed M. ENNAB ¹ ✉, Waleed M. MOMANI ², Anas M. JAIUOSSI ³, Alaa A. ALJABALI ⁴, Murtaza M. TAMBWALA ⁵

¹ Department of Clinical Sciences and Vascular Surgery, Faculty of Medicine, Yarmouk University, Irbid, Jordan; ² Department of Basic Sciences and Microbiology, Faculty of Medicine, Yarmouk University, Irbid, Jordan; ³ Department of Clinical Sciences and General Surgery, Faculty of Medicine, Yarmouk University, Irbid, Jordan; ⁴ Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Yarmouk University, Irbid, Jordan; ⁵ School of Pharmacy and Pharmaceutical Sciences, SAAD Center for Pharmacy and Diabetes, Ulster University, Coleraine, UK

COVID-19 is a global and highly contagious pandemic with substantial morbidity and mortality. It has affected the medical care of other diseases with recommendations to postpone elective surgical procedures to decrease infection rates. New surgical triage guidelines have been recommended by the Vascular Surgery Society to manage urgent and emergent conditions. COVID-19 patients especially severe cases have several pathological findings as demonstrated by clinical research. Some of these pathologies including thrombocytopenia, coagulopathy, and cardiac involvement are important to be considered by the vascular surgeon. The aim of this article was to review the literature and discuss these risks in relation to vascular surgery.

KEY WORDS: COVID-19; SARS-CoV-2; Thrombocytopenia; Vascular surgical procedures; Coronavirus